NRP1 inhibition modulates radiosensitivity of medulloblastoma by targeting cancer stem cells
2022 · Cancer Cell International · 10 citations
https://doi.org/10.1186/s12935-022-02796-4
C
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
45
Papers
239
Citations
8
h-index
8
i10-index
Caifeng Gong is an academic researcher from Chinese Academy of Medical Sciences & Peking Union Medical College. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Pancreatic and Hepatic Oncology Research & Nanoparticle-Based Drug Delivery. The author has an h-index of 8, co-authored 39 publications.
ORCID: 0000-0002-1864-8206Papers by this author
worksChinese expert recommendations on management of hepatocellular carcinoma during COVID-19 pandemic: a nationwide multicenter survey
2021 · HPB · 6 citations
https://doi.org/10.1016/j.hpb.2021.07.002
Abnormal generation of IL-17A represses tumor infiltration of stem-like exhausted CD8+ T cells to demote the antitumor immunity
2023 · BMC Medicine · 6 citations
https://doi.org/10.1186/s12916-023-03026-y
TPP1 is associated with risk of advanced precursors and cervical cancer survival
2024 · PLoS ONE · 3 citations
https://doi.org/10.1371/journal.pone.0298118
Cost-effectiveness of trastuzumab deruxtecan as a second-line treatment for HER2-mutant advanced non-small cell lung cancer
2025 · Human Vaccines & Immunotherapeutics · 1 citations
https://doi.org/10.1080/21645515.2025.2468070
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat